Cargando…
Pyoderma gangrenosum associated with chronic refractory pouchitis: a case successfully treated with infliximab
Pouchitis-associated pyoderma gangrenosum (PG) is rare, with only a few cases reported in the literature. Here we report a rare case of chronic refractory pouchitis-associated PG successfully treated with infliximab (IFX). A 43-year-old Caucasian male, with a past medical history of chronic refracto...
Autores principales: | Koumaki, Dimitra, Orfanoudaki, Eleni, Machaira, Angeliki, Lagoudaki, Eleni, Krasagakis, Konstantinos, Koutroubakis, Ioannis E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hellenic Society of Gastroenterology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7315701/ https://www.ncbi.nlm.nih.gov/pubmed/32624666 http://dx.doi.org/10.20524/aog.2020.0500 |
Ejemplares similares
-
Use of vedolizumab in a patient with chronic and refractory pouchitis
por: Orfanoudaki, Eleni, et al.
Publicado: (2018) -
Pyoderma gangrenosum in pregnancy successfully treated with infliximab and prednisone
por: Stiegler, Julia D., et al.
Publicado: (2017) -
Infliximab in treatment of idiopathic refractory childhood pyoderma gangrenosum (PG)
por: Salehzadeh, Farhad, et al.
Publicado: (2019) -
Successful Long-Term Use of Infliximab in Refractory Pouchitis in an Adolescent
por: Yeates, Jessica, et al.
Publicado: (2010) -
Suppression of pathergy in pyoderma gangrenosum with infliximab allowing for successful tendon debridement
por: Leiphart, Paul A., et al.
Publicado: (2017)